37 results
20-F/A
2023 FY
IPCIF
Intellipharmaceutics International Inc.
6 Feb 24
Annual report (foreign) (amended)
12:00am
to a foreign private issuer. For example, the annual report on Form 10-K requires domestic issuers to disclose executive compensation information … 51-102F6 – Statement of Executive Compensation. Each member of the Compensation Committee has sufficient experience in order to make decisions
6-K
EX-99.2
IPCIF
Intellipharmaceutics International Inc.
6 Oct 23
Annual Meeting of Shareholders
11:33am
compliance services for the Company and its subsidiaries.
All other fees related to internal control reviews.
EXECUTIVE COMPENSATION
Compensation … and management team. Accordingly, the trend in total shareholder return may not directly correlate to levels of executive compensation. See the above
20-F/A
2021 FY
IPCIF
Intellipharmaceutics International Inc.
6 May 22
Annual report (foreign) (amended)
7:54pm
report on Form 10-K requires domestic issuers to disclose executive compensation information on an individual basis with specific disclosure regarding … , Madhani and Keirstead, each of whom is considered “independent” within the meaning of section 2.4 of Form 51-102F6 – Statement of Executive Compensation. Each
6-K
EX-99.2
IPCIF
Intellipharmaceutics International Inc.
29 Apr 22
Annual & Special Meeting of Shareholders
11:43am
– Statement of Executive Compensation. Each member of the Compensation Committee has sufficient experience in order to make decisions on the suitability … team. Accordingly, the trend in total shareholder return may not directly correlate to levels of executive compensation. See the above discussion
6-K
EX-99.1
3c7q 1af4l0mf
28 Feb 22
Primary Document
9:56pm
6-K
EX-99.2
56azn
6 Jan 22
Annual & Special Meeting of Shareholders
5:19pm
6-K
EX-99.1
ac21c32bbz4vz
1 Mar 21
Primary Document
8:21am
6-K
EX-99.2
hy9og3xn
24 Nov 20
Annual & Special Meeting of Shareholders
12:00am
6-K
EX-99.1
1g1k0ba39gd64s
28 Feb 20
Primary Document
4:42pm
424B3
wx6hh9c6kwe3eff0gq
29 May 19
Prospectus supplement
3:18pm
424B3
oz2bla7
29 May 19
Prospectus supplement
3:13pm
6-K
EX-99.2
e9dw rl3c0j
28 May 19
Annual & Special Meeting of Shareholders
4:41pm
20-F/A
4l5n 4fcx2fscasak
4 Mar 19
Annual report (foreign) (amended)
7:05am
424B4
nlllv12ktckvqmpg07q
15 Oct 18
Prospectus supplement with pricing info
7:34am
F-1/A
kfuvqb4z34409agtvst7
11 Oct 18
Registration statement (foreign) (amended)
6:41am